Health 2.0′s Role in a World of “Data Liberacion”

This panel includes speakers Kenneth Buetow (Associate Director, BioInformatics, National Cancer Institute & Founder, caBIG), Patrick Soon-Shiong (Executive Chairman, Abraxis Health), and Josh Sommer (Executive Director, Chordoma Foundation). Coming together to discuss how the Health 2.0 community can get involved in working with data and services, this panel approaches the issue from a variety of perspectives.

Patrick Soon-Shiong Excerpt

Patrick Soon-Shiong, Executive Chairman, Abraxis Health

Patrick has had (at least) three groundbreaking careers so far. Graduating medical school in South
Africa during the apartheid era, he later moved to the faculty at UCLA where he performed the world’s
first encapsulated human islet transplant. He next founded two multi-billion dollar pharmaceutical
companies; injectables maker American Pharma Partners (APP) and Abraxis Bioscience which
developed Patrick’s research in nanoparticle delivery into the breast cancer drug Abraxane. Following
the sale of APP to Fresnius, and with the founding of the Health Transformation Institute, board
membership in Dossia and much, much more, Abraxis Health is now trying nothing short of funding
and leading a transformation of health information technology by using it to connect bioscience, care
delivery and finance.

thumbnail_2_735c04f7_v1

Health 2.0′s Role in a World of “Data Liberacion̶ ...

This panel includes speakers Kenneth Buetow (Associate Director, BioInformatics, National Cancer Institute & Founder, caBIG), Patrick Soon-Shiong (Executive Chairman, Abraxis Health), and Josh Sommer (Executive Director, Chordoma Foundation). Coming together to discuss how the Health 2.0 community can get involved in working with data and services, this panel approaches the issue from a variety of perspectives.

thumbnail_2_763ebd56_v1

Patrick Soon-Shiong Excerpt

Patrick Soon-Shiong, Executive Chairman, Abraxis Health Patrick has had (at least) three groundbreaking careers so far. Graduating medical school in South Africa during the apartheid era, he later moved to the faculty at UCLA where he performed the world’s first encapsulated human islet transplant. He next founded two multi-billion dollar pharmaceutical companies; injectables maker American Pharma Partners (APP) and Abraxis Bioscience which developed Patrick’s researc ...